Novartis, Amgen and Eli Lilly are betting that slashing levels of a particularly bad form of cholesterol could deliver the ...

New research has shown that GLP‑1 weight-loss drugs deliver protection against heart attacks, strokes and premature death ...

Share on Pinterest A new study found that GLP1-RA medications may help lower the risk of a cardiovascular event in people with type 2 diabetes. Getty Images Researchers say GLP-1 drugs prescribed for ...

Learn how GLP-1 drugs may protect the heart by lowering inflammation, improving blood vessels, and reducing key risk factors.

Real-world data show semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) are linked with lower risk of major heart problems in people with type 2 diabetes. Researchers used national ...

A sweeping review of more than 90,000 patients shows GLP-1 receptor agonists, first developed for type 2 diabetes and later approved for weight loss, reduced major cardiovascular events by roughly 13% ...

A large-scale analysis suggests that GLP-1 receptor agonists may do more than manage weight or blood sugar. New research ...

People with Type 2 diabetes who combined healthy lifestyle habits with GLP-1 receptor agonist (GLP-1 RA) medications had a greater reduction in risk of major adverse cardiovascular events, including ...

A new study finds quitting GLP-1 drugs like Ozempic can reverse health gains and increase heart health risks. Patients who stopped taking the medication saw a higher risk for heart attack, stroke, or ...

Share on Pinterest Weight loss drugs could help improve health outcomes in people with heart failure. The Good Brigade/Getty Images Researchers report that the weight loss drugs semaglutide and ...